跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule
Approved
STANDARD
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule
Juno Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
84e6bbbd1c3ffdf3
Company
Juno Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
84e6bbbd1c3ffdf3
Product Name
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule
Artg Id
232701
Artg Name
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule
Sponsor
Juno Pharmaceuticals Pty Ltd
Company Detail Path
/organization/juno-pharmaceuticals-pty-ltd
Artg Date
2015-11-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c9a9f5494b30402a051d24a021959e5d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e89f4f5e107047adee49dc157df634cd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
84e6bbbd1c3ffdf3
Type
Standard
Back to TGA Approvals